70 related articles for article (PubMed ID: 32729818)
1. Etelcalcetide versus placebo for secondary hyperparathyroidism in patients receiving hemodialysis: A meta-analysis of randomized controlled trials.
Zhu Y; Ou J; Liu X; Xie Z
Clin Nephrol; 2020 Oct; 94(4):173-180. PubMed ID: 32729818
[TBL] [Abstract][Full Text] [Related]
2. Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore.
Khan BA; Qu X; Hua Y; Javaid MM
Cureus; 2023 Nov; 15(11):e48186. PubMed ID: 38050530
[TBL] [Abstract][Full Text] [Related]
3. Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide.
Cozzolino M; Galassi A; Conte F; Mangano M; Di Lullo L; Bellasi A
Ther Clin Risk Manag; 2017; 13():679-689. PubMed ID: 28615947
[TBL] [Abstract][Full Text] [Related]
4. Managing hyperparathyroidism in hemodialysis: role of etelcalcetide.
Eidman KE; Wetmore JB
Int J Nephrol Renovasc Dis; 2018; 11():69-80. PubMed ID: 29440923
[TBL] [Abstract][Full Text] [Related]
5. A Prospective, Randomized Clinical Trial of Etelcalcetide in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism (the DUET Trial).
Itano Y; Kato S; Tsuboi M; Kasuga H; Tsuruta Y; Sato F; Hishida M; Ishimoto T; Kosugi T; Ando M; Kuwatsuka Y; Maruyama S
Kidney Int Rep; 2020 Dec; 5(12):2168-2177. PubMed ID: 33305109
[TBL] [Abstract][Full Text] [Related]
6. Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis.
Ye J; Deng G; Gao F
Drug Des Devel Ther; 2018; 12():901-909. PubMed ID: 29719376
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials.
Wakamatsu T; Yamamoto S; Matsuo K; Taniguchi M; Hamano T; Fukagawa M; Kazama JJ
J Bone Miner Metab; 2024 May; 42(3):316-325. PubMed ID: 38536478
[TBL] [Abstract][Full Text] [Related]
8. The effect of parathyroid hormone lowering by etelcalcetide therapy on calcification propensity and calciprotein particles in hemodialysis patients.
Thiem U; Lenz J; Haller MC; Pasch A; Smith ER; Cejka D
Clin Kidney J; 2024 Jun; 17(6):sfae097. PubMed ID: 38919277
[TBL] [Abstract][Full Text] [Related]
9. Full thermal ablation versus partial thermal ablation for secondary hyperparathyroidism: A meta-analysis.
Gong L; Liu X; Yang Q; Jiang W; Liu X; Li X; Xu W
Medicine (Baltimore); 2023 Dec; 102(48):e36422. PubMed ID: 38050273
[TBL] [Abstract][Full Text] [Related]
10. An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving.
Carta A; Tedesco M; Mescia F; Manenti C; Lucca B; Verzeletti F; Guerini A; Terni FG; Zubani R; Guerini S; Valzorio B; Jeannin G; Carli O; Camerini C; Possenti S; Gaggia P; Alberici F
Kidney Int Rep; 2024 Feb; 9(2):482-485. PubMed ID: 38344732
[No Abstract] [Full Text] [Related]
11. Etelcalcetide (Parsabiv) for Secondary Hyperparathyroidism in Adults With Chronic Kidney Disease on Hemodialysis.
Patel J; Bridgeman MB
P T; 2018 Jul; 43(7):396-399. PubMed ID: 30013296
[TBL] [Abstract][Full Text] [Related]
12. First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Satouchi M; Nosaki K; Takahashi T; Nakagawa K; Aoe K; Kurata T; Sekine A; Horiike A; Fukuhara T; Sugawara S; Umemura S; Saka H; Okamoto I; Yamamoto N; Sakai H; Kishi K; Katakami N; Horinouchi H; Hida T; Okamoto H; Atagi S; Ohira T; Han SR; Noguchi K; Ebiana V; Hotta K
Cancer Sci; 2020 Dec; 111(12):4480-4489. PubMed ID: 32926507
[TBL] [Abstract][Full Text] [Related]
13. Treating Excessive Daytime Sleepiness in Patients With Narcolepsy.
Roth T
J Clin Psychiatry; 2020 Sep; 81(5):. PubMed ID: 32926605
[TBL] [Abstract][Full Text] [Related]
14. Progress in evaluating the status of hepatitis C infection based on the functional changes of hepatic stellate cells (Review).
Wang W; Huang X; Fan X; Yan J; Luan J
Mol Med Rep; 2020 Nov; 22(5):4116-4124. PubMed ID: 33000255
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic markers of erythropoietin deficiency anemia in chronic kidney disease (predialysis) patients.
Yugavathy N; Huri HZ; Kun LS; Bin Abdul Gafor AH; Geot WM; Bavanandan S; Seng WH
Biomark Med; 2020 Aug; 14(12):1099-1108. PubMed ID: 32969247
[No Abstract] [Full Text] [Related]
16. A new concept of motion preservation surgery of the cervical spine: PEEK rods for the posterior cervical region.
Aydin AL; Sasani M; Erbulut DU; Oktenoglu T; Ozer AF
Biomed Mater Eng; 2020; 31(4):235-251. PubMed ID: 32894236
[TBL] [Abstract][Full Text] [Related]
17. Intramedullary antibiotic coated nail in tibial fracture: a systematic review.
Greco T; Vitiello R; Cazzato G; Cianni L; Malerba G; Maccauro G; Perisano C
J Biol Regul Homeost Agents; 2020; 34(3 Suppl. 2):63-69. ADVANCES IN MUSCULOSKELETAL DISEASES AND INFECTIONS - SOTIMI 2019. PubMed ID: 32856442
[TBL] [Abstract][Full Text] [Related]
18. The effect of fluoxetine on body weight, body composition and visceral fat accumulation.
Visser M; Seidell JC; Koppeschaar HP; Smits P
Int J Obes Relat Metab Disord; 1993 May; 17(5):247-53. PubMed ID: 8389333
[TBL] [Abstract][Full Text] [Related]
19. Consequences of endodontic treatment in primary teeth. Part I: A clinical and radiographic study of the influence of formocresol pulpotomy on the life-span of primary molars.
van Amerongen WE; Mulder GR; Vingerling PA
ASDC J Dent Child; 1986; 53(5):364-70. PubMed ID: 3463582
[TBL] [Abstract][Full Text] [Related]
20. Functional anatomy of occipital lobe seizures: an experimental study in rats.
Collins RC; Caston TV
Neurology; 1979 May; 29(5):705-16. PubMed ID: 571569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
